What is Type 2 Diabetes?

Type 2 diabetes is a chronic condition where your body either doesn't produce enough insulin or doesn't use insulin effectively. Insulin is a hormone that helps glucose (sugar) get into your cells for energy.

What are the common symptoms of Type 2 Diabetes?

Common symptoms include increased thirst, frequent urination, increased hunger, fatigue, and blurred vision. Over time, individuals might also experience slow-healing sores or frequent infections.

What causes Type 2 Diabetes?

Type 2 diabetes is often caused by a combination of genetic and lifestyle factors. These can include a family history of diabetes, being overweight or obese, physical inactivity, and certain ethnic backgrounds.

How is Type 2 Diabetes managed?

Management of Type 2 diabetes typically involves lifestyle changes such as diet modification and regular exercise. In some cases, medication or insulin therapy may also be necessary to help control blood sugar levels.

When should I see a doctor for Type 2 Diabetes concerns?

You should see a doctor if you experience any of the symptoms associated with Type 2 diabetes, or if you have risk factors for the condition. Early diagnosis and management are important to prevent complications.

Knowledge Graph · Condition

Type 2 Diabetes

A chronic condition affecting how the body metabolizes glucose.

Authoritative sources

Evidence base

Randomized Controlled Trial · 2025
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
The New England journal of medicine · Davies MJ, Bajaj HS, Broholm C, Eliasen A, et al.
Phase III Clinical Trial · 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
The New England journal of medicine · Nicholls SJ, Pavo I, Bhatt DL, Buse JB, et al.
Randomized Controlled Trial · 2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
The New England journal of medicine · Rosenstock J, Hsia S, Nevarez Ruiz L, Eyde S, et al.
Randomized Controlled Trial · 2025
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Lancet (London, England) · Bonaca MP, Catarig AM, Houlind K, Ludvik B, et al.
Meta-Analysis · 2024
The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials
Phytotherapy research : PTR · Moridpour AH, Kavyani Z, Khosravi S, Farmani E, et al.
Meta-Analysis · 2024
Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
The Journal of clinical endocrinology and metabolism · Uhl S, Choure A, Rouse B, Loblack A, et al.
Randomized Controlled Trial · 2022
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
European heart journal · Agarwal R, Filippatos G, Pitt B, Anker SD, et al.
Randomized Controlled Trial · 2021
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Lancet (London, England) · Davies M, Færch L, Jeppesen OK, Pakseresht A, et al.
Randomized Controlled Trial · 2021
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
The New England journal of medicine · Frías JP, Davies MJ, Rosenstock J, Pérez Manghi FC, et al.
Randomized Controlled Trial · 2021
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
The New England journal of medicine · Pitt B, Filippatos G, Agarwal R, Anker SD, et al.

Where Type 2 Diabetes appears on Kindr Health

Data hub

Menopause Statistics

Wiki

Berberine

This page is part of Kindr Health's public Knowledge Graph. Content is for educational purposes only and is not medical advice.